An infectious disease doctor at Huntsville Hospital says he continues to use the drug hydroxychloroquine to treat some patients with the coronavirus.
The drug, often championed by President Donald Trump, has been the subject of intense nationwide discussion during the pandemic.
A recent retrospective study published in the scientific journal The Lancet showed evidence that hydroxychlorquine had no positive results for hospitalized patients.
WAFF asked Dr. Ali Hassoun of Huntsville Hospital about the article published in The Lancet. He said the type of study and characteristics of the subjects meant that it was not good enough evidence to stop using hydroxychloroquine.
Hassoun says he continues to treat patients with the drug as long as they are not at risk for the side effects.
A top infectious disease expert at UAB Hospital recently told Yellowhammer News that he and his team do not recommend hydroxychloroquine for hospitalized patients.
Most of the published evidence used to fuel media articles on hydroxychloroquine’s ineffectiveness have used studies done on hospitalized subjects.
Another member of the team at UAB, Dr. Turner Overton, is currently helping conduct a trial studying hydroxychloroquine’s ability to treat the coronavirus in its earliest stages.
Hassoun did not reveal in his interviews the condition of the patients to whom he is giving hydroxychloroquine.
Another drug, remdesivir, has shown in studies to be effective at treating hospitalized COVID-19 patients, but the supply is low.
Hassoun told WAFF he is prescribing remdesivir as well.
Henry Thornton is a staff writer for Yellowhammer News. You can contact him by email: henry@new-yhn.local or on Twitter @HenryThornton95
